McDermott is a leading international law firm with 1,000+ lawyers, nine practice areas and 20 offices globally, including Boston and Paris, which provides clients in the health/life sciences, commercial, industrial and financial markets with a comprehensive offering of sophisticated legal services. Our commitment to total client satisfaction is at the core of our business, and leading industry publications have routinely recognized McDermott for its outstanding client service.
Our corporate practice represents a wide spectrum of business interests around the world. Our lawyers are highly skilled business advisors and focus on solving complex problems and acting as strategic partners in the execution of our clients’ capital raising and corporate development plans. Thanks to our full-service offerings, we are able to accompany our clients throughout their various stages of development (including, but not limited to, company formation, fundraising, entry into the global marketspace, commercial partnerships, licensing deals and sales and acquisitions). With our global footprint, we especially excel at cross-border deals, no matter how complex.
Our multidisciplinary, Chambers-ranked Life Sciences Industry Group, which includes 135+ life sciences lawyers worldwide (nearly half of who have advanced technical degrees), has significant experience representing clients in the biotech, medical device, and pharmaceutical industries. Such clients include industry leaders such as Novartis, Voluntis, Servier and Pierre Fabre, but also emerging companies for which McDermott is proud to have created the Life Sciences Entrepreneurs Acceleration Program (LEAP). This program helps qualifying entrepreneurs and young companies avoid costly mistakes and chart their courses to success by providing them with affordable access to strategic legal advice through engagement incentives in the form of deferred fees, discounts, fixed-fee arrangements and/or awards.
Hand-in-hand with our life sciences lawyers, our regulatory practice works from all of our offices to provide coordinated legislative and regulatory services to our global clients. We are on the cutting edge of legislative reform and are adept at handling government regulations across numerous jurisdictions to meet the challenges faced by global organizations. In addition, our FDA practice provides comprehensive regulatory and strategic advice to life sciences companies on the development, manufacture, marketing, promotion and reimbursement of drugs, biologics, devices and other FDA-regulated products. Members of our team have worked at the FDA in legal and regulatory positions and held senior legal and compliance roles in pharmaceutical and biotech companies.